Both in Pharmaceuticals
BioVie vs Vistagen Therapeutics
Over the past year BIVI returned −19.4% and VTGN returned −91.6%; their daily moves had a correlation of 0.05.
BIVI −19.4% VTGN −91.6%Growth of $1, one year, split-adjusted
| Metric | BIVI | VTGN |
|---|---|---|
| Price | $1.54 | $0.2980 |
| Market cap | $13.1M | $13.2M |
| Today | 0.00% | +0.34% |
| 1 month | −28.7% | +17.8% |
| 6 months | +14.1% | −45.4% |
| Year to date | +32.8% | −55.0% |
| 1 year | −17.2% | −91.6% |
| Revenue growth (YoY) | — | +504.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −882.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.3× |
| Net cash | $9.0M | $31.7M |
| Dividend yield | — | — |
| Volatility (60d) | 200.2% | 111.9% |
| Short % of float | 14.8% | 6.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).